CLINICAL UNIT BASED RESEARCH
Alcohol and Drug Abuse Treatment Program
NIDA CTN Northern New England Node
The McLean Alcohol and Drug Abuse Treatment Program (ADATP) is the Regional Research & Training Center (RRTC) for the Northern New England Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN). The primary goal of the CTN is to improve the overall quality of drug abuse treatment in community settings by bringing university-affiliated researchers and community-based clinicians together to design clinical trials testing the effectiveness of behavioral, pharmacological, and integrated behavioral and pharmacological treatment interventions across a broad range of community-based settings and diverse patient populations.
About the Northern New England Node
|
The goal of the Northern New England Node is to combine the expertise of researchers from McLean Hospital, Harvard Medical School, and other area academic institutions with community-based treatment programs to develop and implement addiction treatment studies in the community programs so that patients receive the full benefit of the evolving science of addiction treatment.
The Northern New England Node Community Treatment Programs (CTPs) have excellent clinical reputations in the region, with both the programs and their directors viewed as leaders in the area. These sites offer a broad array of treatment settings, patient characteristics, and diversity in geography (i.e., urban, rural, and suburban), ethnicity, age, gender, psychiatric comorbidity, and levels of care. CTP personnel are interested in participating in clinical research and have genuine enthusiasm for the overall concept and goals of the CTN.
Northern New England Node Newsletter
The
latest Northern New England Node quarterly newsletters are available here in PDF format:
- Volume 7 Issue 2 (Spring 2008)
- Volume 7 Issue 1 (Winter, 2008)
- Volume 6 Issue 3 (Fall, 2007)
- Volume 5 Issue 2 (Summer, 2007)
- Volume 5 Issue 1 (March, 2007)
- Volume 4, Issue 3 (November, 2006)
- Volume 4, Issue 2 (June, 2006)
- Volume 4, Issue 1 (January, 2006)
- Volume 3, Issue 1 (October, 2005)
- Volume 2, Issue 4 (December, 2004)
- Volume 2, Issue 3 (September, 2004)
- Volume 2, Issue 2 (June, 2004)
- Volume 2, Issue 1 (March, 2004)
Regional Research & Training Center profile
The Northern New England Node Regional Research & Training Center (RRTC) in the McLean ADATP is one of seventeen RRTCs across the country. Each RRTC is affiliated with five to eight Community Treatment Programs. The Northern New England RRTC works in collaboration with its affiliated Community Treatment Programs and with the other nodes in the CTN.Node Contact Information
Roger D. Weiss, M.D. - Principal Investigator
Harvard Medical School/
McLean Hospital
115 Mill Street
Belmont, MA 02478Tel: (617) 855-2242
Fax: (617) 855-2699
E-mail: rweiss@mclean.harvard.eduFor questions or comments regarding the Node, contact Marge Maxwell at mmaxwell@mclean.harvard.edu.
CTN - Northern New England Node People
Meet the investigators, staff, co-investigators and consultants affiliated with the Northern New England Node here.
Northern New England Node Community Treatment Programs
Information about community treatment programs affiliated with the Northern New England Node is available here.Current Protocols
Information about the CTN protocols conducted within the Northern New England Node is available here.Publications and Presentations
A list of publications and presentations by CTN Northern New England Node staff is available here.
General CTN Links
- NIDA Home page (www.nida.nih.gov)
- NIDA CTN Page (www.nida.nih.gov/CTN/Index.htm)
- NIDA CTN Livelink (https://livelink.nida.nih.gov/livelink/livelink.exe?func=ll&objid=806579&objaction=open)
- Addiction Technology Transfer Center of New England (www.attc-ne.org)
- CTN Dissemination Library (ctndisseminationlibrary.org/faq.htm)
Other Related Links
- National Institutes of Health (www.nih.gov)
- Office for Human Research Protections (www.hhs.gov/ohrp/)
- Office of Research Integrity (ori.hhs.gov)
Note: The information on this site has not been reviewed by the National Institute on Drug Abuse and does not necessarily reflect the views of NIDA.
